Aberrant high expression level of MORC2 is a common character in multiple cancers
Qian-shan Ding1,2, Li Zhang3, Bi-cheng Wang4, Zhi Zeng5, Xian-qiong Zou6, Peng-bo Cao7, Guang-ming Zhou7, Meng Tang1, Lu Wu2, Lian-lian Wu2, Hong-gang Yu2, Yong Guo6, Fu-xiang Zhou1
1Department of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Clinical Cancer Study Center, Zhongnan Hospital, Wuhan University, Wuhan, 430071, China
2Department of Gastroenterology, Institute for Gastroenterology and Hepatology, Renmin Hospital of Wuhan University, Wuhan 430060, China
3Department of Anatomical and Cellular Pathology, State Key Laboratory of Oncology in South China, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China
4Department of Pathology, Zhongnan Hospital, Wuhan University, Wuhan 430071, China
5Department of Pathology, Renmin Hospital of Wuhan University, Wuhan 430060, China
6College of Biotechnology, Guilin Medical University, Guilin 541100, China
7The State Key Laboratory of Proteomics, Beijing Proteome Research Center, Beijing Institute of Radiation Medicine, Beijing 100850, China
Tài liệu tham khảo
Thông tin
Thông tin xuất bản
Human Pathology
Tập 76
58-67
Thông tin tác giả